GALECTIN THERAPEUTICS INC ($GALT)
Filing Information
| Accession Number | 0001133416-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
180,000
Total Value
$233,387.57
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 67,614 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 2, 2026 | Sale | 13,914 | $4.20 | $58,394.28 | 53,700 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 5, 2026 | Sale | 25,732 | $3.90 | $100,298.19 | 27,968 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 6, 2026 | Sale | 20,354 | $3.67 | $74,695.11 | 7,614 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Unit | Derivative | Jan 1, 2026 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |